Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2004-12-20 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA WANTZENAU (67610), Bas-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA WANTZENAU : revenue, balance sheet and financial ratios
PHARMACIE DE LA WANTZENAU is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA WANTZENAU (67610),
this company of category PME
shows in 2022 a revenue of 7.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA WANTZENAU (SIREN 479971103)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
7 382 109 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
42 484 €
55 674 €
286 403 €
188 126 €
146 084 €
236 718 €
240 700 €
288 165 €
EBITDA
N/C
151 985 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
0.8%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DE LA WANTZENAU generates positive net income of 42 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 288 k€ -> 42 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
42 484 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 111%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
110.706%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
40.787%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA WANTZENAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
29.46
19.768
12.002
8.428
23.822
3.222
93.231
110.706
Financial autonomy
61.507
66.597
75.021
78.617
68.76
75.615
36.921
40.787
Repayment capacity
None
None
None
None
None
None
57.52
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
0.786%
None%
Sector positioning
Debt ratio
110.712023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average+36 pts over 3 years
In 2023, the debt ratio of PHARMACIE DE LA WANTZENAU (110.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
40.79%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average-35 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DE LA WANTZENAU (40.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
57.52 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Watch
In 2022, the repayment capacity of PHARMACIE DE LA WANTZENAU (57.52) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 200.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
200.061
Liquidity indicators evolution PHARMACIE DE LA WANTZENAU
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
127.91
146.12
183.9
202.8
293.153
191.557
138.394
200.061
Interest coverage
None
None
None
None
None
None
10.428
None
Sector positioning
Liquidity ratio
200.062023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good
In 2023, the liquidity ratio of PHARMACIE DE LA WANTZENAU (200.06) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
10.43x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent
In 2022, the interest coverage of PHARMACIE DE LA WANTZENAU (10.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA WANTZENAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
1 552 900 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
57
0
Customer payment term (days)
0
0
0
0
0
0
10
0
Supplier payment term (days)
0
0
0
0
0
0
59
0
Positioning of PHARMACIE DE LA WANTZENAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE LA WANTZENAU is estimated at
501 288 €
(range 304 857€ - 704 699€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
304k€501k€704k€
501 288 €Range: 304 857€ - 704 699€
NAF 5 année 2023
Valuation method used
Net Income Multiple
42 484 €
×
11.8x
=501 289 €
Range: 304 858€ - 704 700€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA WANTZENAU with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA WANTZENAU
What is the revenue of PHARMACIE DE LA WANTZENAU ?
The revenue of PHARMACIE DE LA WANTZENAU in 2022 is 7.4 M€.
Is PHARMACIE DE LA WANTZENAU profitable?
Yes, PHARMACIE DE LA WANTZENAU generated a net profit of 42 k€ in 2023.
Where is the headquarters of PHARMACIE DE LA WANTZENAU ?
The headquarters of PHARMACIE DE LA WANTZENAU is located in LA WANTZENAU (67610), in the department Bas-Rhin.
Where to find the tax return of PHARMACIE DE LA WANTZENAU ?
The tax return of PHARMACIE DE LA WANTZENAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA WANTZENAU operate?
PHARMACIE DE LA WANTZENAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart